MENU
+Compare
JBIO
Stock ticker: NASDAQ
AS OF
Jun 27, 11:09 AM (EDT)
Price
$9.25
Change
-$0.00 (-0.00%)
Capitalization
298.18M

JBIO Jade Biosciences Inc Forecast, Technical & Fundamental Analysis

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases... Show more

JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for JBIO with price predictions
Jun 26, 2025

Momentum Indicator for JBIO turns positive, indicating new upward trend

JBIO saw its Momentum Indicator move above the 0 level on June 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for JBIO just turned positive on June 18, 2025. Looking at past instances where JBIO's MACD turned positive, the stock continued to rise in of 30 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JBIO advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for JBIO moved out of overbought territory on June 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JBIO broke above its upper Bollinger Band on June 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for JBIO entered a downward trend on June 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.566). P/E Ratio (0.000) is within average values for comparable stocks, (58.942). JBIO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.298). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.026).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

JBIO is expected to report earnings to fall 93.78% to -41 cents per share on May 19

Jade Biosciences Inc JBIO Stock Earnings Reports
Q1'25
Est.
$-0.41
Q4'24
Missed
by $6.21
The last earnings report on March 26 showed earnings per share of -661 cents, missing the estimate of -40 cents. With 6.60K shares outstanding, the current market capitalization sits at 298.18M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBCVX24.08N/A
N/A
Fidelity Blue Chip Value
TEMLX8.80N/A
N/A
Nuveen Emerging Markets Eq R6
DHIAX19.43N/A
N/A
Diamond Hill International Inv
AEIMX8.56N/A
N/A
American Century Equity Income G
PAHWX8.40N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps A

JBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
-11.99%
OVID - JBIO
79%
Closely correlated
+9.06%
KNSA - JBIO
35%
Loosely correlated
+0.39%
SYRE - JBIO
30%
Poorly correlated
+3.96%
KPRX - JBIO
29%
Poorly correlated
N/A
VANI - JBIO
26%
Poorly correlated
+3.15%
More

Groups containing JBIO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
-11.99%
JBIO
(2 stocks)
99%
Closely correlated
-1.40%